AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18237355
Drug: Alternative treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatments (MVP, vinorelbine, active symptom control)
Trial: 10987238
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus manual lymphatic drainage (MLD) 8 times in 2 weeks and training in self-massage
Trial: 10987238
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (compression garment, exercises, information about lymphedema and skin care)
Trial: 8291869
Drug: Polyestradiol phosphate
RxNorm normalized name: POLYESTRADIOL PHOSPHATE
DrugBank: Polyestradiol phosphate (DB09369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polyestradiol phosphate (PEP) 160 mg/month
Trial: 3034016
Drug: Ramipril (HOE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (HOE 498) 5 or 10 mg
Trial: 24507830
Drug: High-dose fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fluticasone (1,000 μg/d)
Trial: 24507830
Drug: Low-dose fluticasone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fluticasone (250 μg/d)
Trial: 23129488
Drug: Melatonin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (0.5 mg to 12 mg depending on response)
Trial: 10877005
Drug: Fluvoxamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (50 mg)
Trial: 18621928
Drug: Rivaroxaban 30
RxNorm normalized name: rivaroxaban 30-Day Starter Pack (42-15 MG Oral Tablets & 9-20 MG Oral Tablets)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 30 mg once daily
Trial: 18621928
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (low-molecular-weight heparin followed by vitamin K antagonists)
Trial: 16100132
Drug: Disease management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease management (DM) program with care coordination, family support, teaching, and monitoring of therapies from a team of advanced-practice nurses, a geriatrician, and a pulmonologist for 2 months post-hospital discharge.
Trial: 10354963
Drug: lamivudine/zidovudine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine/zidovudine combination tablet after an overnight fast
Trial: 10354963
Drug: lamivudine 150
RxNorm normalized name: lamivudine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine 150 mg tablet and zidovudine 300 mg tablet administered concurrently after an overnight fast
Trial: 10354963
Drug: lamivudine/zidovudine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine/zidovudine combination tablet 5 minutes after a standardized high-fat breakfast
Trial: 7796357
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg four times daily
Trial: 678769
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of depot penicillin at the time of suture
Trial: 27480573
Drug: Equicrestal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equicrestal implants (G1, n=28)
Trial: 27480573
Drug: Subcrestal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcrestal implants (G2, n=27)
Trial: 26156901
Drug: Quetiapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (mean 500 mg/day)
Trial: 26156901
Drug: Risperidone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (mean 5.2 mg/day)
Trial: 19469706
Drug: sorivudine cream
RxNorm normalized name: Brivudine
DrugBank: Sorivudine (DB11998)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorivudine cream
Trial: 16753975
Drug: High frequency
RxNorm normalized name: ALCOHOL 0.7 mL in 1 mL TOPICAL SOLUTION [enMotion Foam High Frequency Use]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High frequency chest wall oscillation (HFCWO) administered twice-daily for 15 min duration plus standard care
Trial: 9286741
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1,000 mg/day for 8 days)
Trial: 8356859
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with 20 ml of 0.125% bupivacaine and 2 mg of morphine administered epidurally about 30 min before the end of the operation
Trial: 9279969
Drug: Atenolol 50-100
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50-100 mg day-1
Trial: 2887190
Drug: Labetalol 200-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol 200-800 mg day-1
Trial: 2887190
Drug: Pindolol 10-30
RxNorm normalized name: pindolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 10-30 mg day-1
Trial: 2887190
Drug: Captopril 25-100
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25-100 mg day-1
Trial: 6130944
Drug: All four
RxNorm normalized name: Jackson's The Original All Fours
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All four drugs
Trial: 30382819
Drug: Open lung
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open lung approach (OLA) with PEEP titration, external PEEP selected was 6 ± 0.8 cmH2O.
Trial: 30382819
Drug: Open lung
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open lung approach (OLA) with PEEP titration.
Trial: 27965838
Drug: Immediate tumor
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate tumor resection after stopping chemotherapy
Trial: 27965838
Drug: Completion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Completion of chemotherapy before surgery
Trial: 18975535
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ketamine (300-400 microg x kg(‐1) x hr(‐))
Trial: 16875724
Drug: Exercise Prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise Prescription Model (EPM) - 30-minute continuous activity, 3-4 days per week
Trial: 12954465
Drug: Instrumental Activities
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instrumental Activities of Daily Living
Trial: 10812039
Drug: 0.5 mol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mol/L sodium lactate infused over 20 min
Trial: 9017056
Drug: Amvisc with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amvisc with aspiration and topical timolol
Trial: 1517815
Drug: Intravenous cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cisplatin (CDDP)
Trial: 24531687
Drug: PG201 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PG201 600 mg
Trial: 22259009
Drug: Regadenoson 0.4
RxNorm normalized name: REGADENOSON 0.4MG/5ML INJ VIL 5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regadenoson 0.4 mg intravenous injection
Trial: 19473285
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg taken once daily
Trial: 15365570
Drug: Irinotecan monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan monotherapy (350 mg m(‐2) once every 3 weeks)
Trial: 11239541
Drug: Tibolone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (2.5 mg; n = 50)
Trial: 11239541
Drug: Continuous combined
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous combined 17-beta-estradiol (2 mg) and norethindrone acetate (1 mg; n = 50)
Trial: 9737353
Drug: prednisolone, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisolone, 10 mg twice daily
Trial: 7508194
Drug: Human galanin
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human galanin (500 micrograms) in saline (100 ml)
Trial: 7508194
Drug: Saline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (100 ml)
Trial: 2727326
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of breathing patterns
Trial: 26220762
Drug: Alfaxalone-dexmedetomidine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfaxalone-dexmedetomidine (0.3 mg 100 mL(‐1))
Trial: 19854114
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of estrogen receptor (ER) negative tumor
Trial: 14722364
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (20 mg elemental iron)
Trial: 14722364
Drug: Nutrition education
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition education with supplementation (20 mg elemental iron)
Trial: 10745678
Drug: 750 mL
RxNorm normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mL black currant/apple juice (1:1)
Trial: 10745678
Drug: 1000 mL
RxNorm normalized name: TPN Bag 1000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mL black currant/apple juice (1:1)
Trial: 10745678
Drug: 1500 mL
RxNorm normalized name: Bag/Pump Set 1500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mL black currant/apple juice (1:1)
Trial: 10745678
Drug: Juice intervention
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juice intervention (all doses)
Trial: 3881960
Drug: Combined estrogen-androgen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined estrogen-androgen drug
Trial: 29790266
Drug: Oral clindamycin
RxNorm normalized name: clindamycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clindamycin 300 mg twice daily for 5 days
Trial: 26600073
Drug: Seven days
RxNorm normalized name: Sevenfact
DrugBank: Coagulation factor VIIa Recombinant Human (DB00036)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven days a week individual therapy
Trial: 26600073
Drug: Five days
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five days a week circuit class therapy
Trial: 22305998
Drug: aliskiren/amlodipine/HCTZ 300/10/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aliskiren/amlodipine/HCTZ 300/10/25 mg
Trial: 22305998
Drug: aliskiren/amlodipine 300/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aliskiren/amlodipine 300/10 mg
Trial: 18363895
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg clevudine once daily for 12 weeks
Trial: 18363895
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg clevudine once daily for 12 weeks
Trial: 18363895
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg clevudine once daily for 12 weeks
Trial: 16240065
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation using an oral sodium phosphate solution and rectal enema on the morning of the procedure.
Trial: 16240065
Drug: No bowel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No bowel preparation (control group).
Trial: 16240065
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation group.
Trial: 29185780
Drug: Saffron capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron capsules (15 mg/twice daily)
Trial: 23926422
Drug: Quetiapine (25-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (25-100 mg/day, mean 67.6 mg/day)
Trial: 23926422
Drug: Haloperidol (0.5-2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.5-2.0 mg/day, mean 0.8 mg/day)
Trial: 17198445
Drug: Pulse intravenous
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse intravenous methylprednisolone (1000 mg for 4 days) plus cyclophosphamide (500 mg for 1 day)
Trial: 17198445
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (1-2 mg/kg/day for 28 days) plus azathioprine (1.5 mg/kg/day)
Trial: 12749513
Drug: Dirithromycin 500
RxNorm normalized name: Dirithromycin
DrugBank: Dirithromycin (DB00954)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dirithromycin 500 mg QD for 5 days
Trial: 12749513
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg QD on day 1 and 250 mg QD on days 2 to 5
Trial: 1316079
Drug: Once-daily 400
RxNorm normalized name: eslicarbazepine
DrugBank: Eslicarbazepine (DB14575)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily 400 mg lomefloxacin
Trial: 1316079
Drug: Twice-daily 400
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily 400 mg lomefloxacin
Trial: 2931232
Drug: Nitrendipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (20 mg once a day)
Trial: 2931232
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 tablet once a day)
Trial: 24854041
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump (continuous subcutaneous insulin infusion [CSII])
Trial: 21781200
Drug: Gum chewing
RxNorm normalized name: Nicotine (as nicotine polacrilex) 4 mg oral gum chewing gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gum chewing exercise (twice daily for 5 minutes over 4 weeks)
Trial: 18626263
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of 1% testosterone gel (Testogel)
Trial: 16034518
Drug: Rebeccamycin analogue
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebeccamycin analogue (RA) 500 mg/m(2) as a 1 hr infusion repeated every 3 weeks (Arm A)
Trial: 16034518
Drug: Rebeccamycin analogue
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebeccamycin analogue (RA) 140 mg/m(2)/day x 5 days repeated every 3 weeks (Arm B)
Trial: 10539878
Drug: Preoperative transfusion
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative transfusion regimen (conservative to bring hemoglobin concentration to between 9 and 11 g/dl)
Trial: 8955454
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nalidixic acid and metronidazole
Trial: 31991898
Drug: High-dose omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose omega-3 and omega-6 fatty acids supplementation with antioxidant vitamins (20 mL containing 810 mg Eicosapentaenoic acid, 4140 mg Docosahexaenoic acid, 1800 mg gamma-Linolenic acid, 3150 mg Linoleic acid, 0.6 mg vitamin A, 22 mg vitamin E, 760 mg pure γ-tocopherol)
Trial: 28986051
Drug: Intravenous 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 0.2 mg/kg dexamethasone (group D)
Trial: 25060792
Drug: Polyphenol-rich olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich olive oil (366 mg/kg)
Trial: 25060792
Drug: Polyphenol-poor olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-poor olive oil (2.7 mg/kg)
Trial: 11270012
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl administered 15 min before surgery (group I)
Trial: 11270012
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl administered 15 min before waking at the end of the operation (group II)
Trial: 9509205
Drug: Propofol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.5 mg.kg‐1
Trial: 9509205
Drug: Thiopentone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone 1.0 mg.kg‐1
Trial: 7830998
Drug: C3F8, SF6,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C3F8, SF6, silicone oil as postoperative tamponading agents
Trial: 2905250
Drug: Roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxatidine acetate 150 mg daily at 9 pm for 14 days
Trial: 30121609
Drug: Triple pill
RxNorm normalized name: Triple Wormer Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple pill (fixed low-dose combination of three antihypertensive drugs)
Trial: 26253237
Drug: Both arms
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both arms (supported self-management and standard treatment)
Trial: 18281242
Drug: Pre-ovulatory pertubation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-ovulatory pertubation with low-dose lignocaine
Trial: 16532491
Drug: Glycoprotein (GP)
RxNorm normalized name: Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein (GP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycoprotein (GP) IIb/IIIa inhibitors
Trial: 12649057
Drug: Cognitive-behavioral smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral smoking cessation treatment plus moderate-intensity physical activity
Trial: 11573317
Drug: Sting-Aid (aluminum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sting-Aid (aluminum sulfate solution)
Trial: 8139627
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no epoetin treatment)
Trial: 26169781
Drug: Prenatal oral
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal oral vitamin D3 supplementation (4200 IU/wk)
Trial: 26169781
Drug: Prenatal oral
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal oral vitamin D3 supplementation (16,800 IU/wk)
Trial: 26169781
Drug: Prenatal oral
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal oral vitamin D3 supplementation (28,000 IU/wk)
Trial: 26169781
Drug: Postpartum oral
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postpartum oral vitamin D3 supplementation (28,000 IU/wk)
Trial: 23454404
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg desmopressin orally disintegrating tablet once daily
Trial: 21570355
Drug: MRKAd5 HIV‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRKAd5 HIV‐1 vaccine
Trial: 16339157
Drug: Digoxin at
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin at SDC 0.5-0.9 ng/mL
Trial: 16339157
Drug: Digoxin at
RxNorm normalized name: Digoxin
DrugBank: Digoxin (DB00390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Digoxin at SDC >=1.0 ng/mL
Trial: 11132321
Drug: Recombinant growth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant growth hormone (rGH) administered subcutaneously at a dose of 0.5 lU/kg per day for 28 days
Trial: 11132321
Drug: Recombinant growth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant growth hormone (rGH)
Trial: 26325557
Drug: Finerenone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finerenone 7.5 mg/d
Trial: 26325557
Drug: Finerenone 10
RxNorm normalized name: finerenone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finerenone 10 mg/d
Trial: 26325557
Drug: Finerenone 15
RxNorm normalized name: Finerenone
DrugBank: Finerenone (DB16165)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Finerenone 15 mg/d
Trial: 26325557
Drug: Finerenone 20
RxNorm normalized name: finerenone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finerenone 20 mg/d
Trial: 21527115
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + pioglitazone
Trial: 21527115
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + glimepiride
Trial: 18958842
Drug: glimepiride (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glimepiride (3 mg daily)
Trial: 12663295
Drug: Oligofructose-supplemented cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligofructose-supplemented cereal (0.55 g/15 g cereal)
Trial: 12663295
Drug: Cereal fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cereal fortified with zinc (1 mg/15 g cereal)
Trial: 8633815
Drug: Nevirapine, zidovudine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine, zidovudine, and didanosine (triple-combination regimen)
Trial: 8633815
Drug: Zidovudine and
RxNorm normalized name: zidovudine and lamivudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine and didanosine (double-combination regimen)